Ellipse Technologies Withdraws IPO

Having agreed to be acquired by NuVasive, Ellipse Technologies has withdrawn plans for a US $75MM initial public offering filed in 4Q15.

Source: Renaissance Capital

NuVasive's acquisition of Ellipse represents its entry into the early onset and idiopathic scoliosis treatment arena, and could lead to partnerships in the treatment of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us